NeoGenomics to Participate in Upcoming Investor Conferences

FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:

• Stephens Annual Investment Conference in Nashville, TN
  Company presentation on Wednesday, November 19, at 1:00 pm CT, accessible here
• Piper Sandler 37th Annual Healthcare Conference in New York, NY
  Fireside chat on Tuesday, December 2, at 2:30 pm ET, accessible here

Live and archived webcasts of the sessions may be viewed on the Investor Relations section of the Company’s website at ir.neogenomics.com.

About NeoGenomics

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the US and a CAP-accredited full-service sample-processing laboratory in Cambridge, United Kingdom.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251105900007/en/

Investor Contact
Kendra Webster
[email protected]

Media Contact
Andrea Sampson
[email protected]

Source: NeoGenomics, Inc.

You May Also Be Interested In

• The More Life Company Corp. Announces Completion of Name Change From Mountain Valley MD Holdings Inc.
• usecure launches uHealth, the defining product for Human Risk Intelligence
• Puori Launches Single-Ingredient Unflavored Whey Protein Powder